Financial statements Abbott Medical
Cash inflows of ABBOTT MEDICAL
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | -24 225 449,99 | 17 474 755,04 | -7 452 487,76 | -13 772 346,29 | 9 618 800,46 |
| Net cash flow from investing activities | -8 444 232,92 | -4 508 838,88 | 15 236 136,72 | -6 963 834,72 | -9 568 707,30 |
| Net cash flow from financial activities | 32 416 615,88 | -18 613 179,10 | -7 270 274,97 | 31 848 628,52 | 0,00 |
| Total net cash flow | -253 067,03 | -5 647 262,94 | 513 373,99 | 11 112 447,51 | 50 093,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.